scholarly journals COVID‐19‐related coagulopathy: a review of pathophysiology and pharmaceutical management

2021 ◽  
Author(s):  
Mahdi Kohansal Vajari ◽  
Mahsa Shirin ◽  
Atieh Pourbagheri‐Sigaroodi ◽  
Mohammad Esmaeil Akbari ◽  
Hassan Abolghasemi ◽  
...  
Keyword(s):  
Pharmaceutical Management

Understanding the pharmaceutical approach to pain management in canine osteoarthritis

2021 ◽  
Vol 26 (6) ◽  
pp. 73-80
Author(s):  
Hannah Capon
Keyword(s):  
Surveillance System ◽  
Best Practice ◽  
Animal Health ◽  
Management Strategies ◽  
Companion Animal ◽  
Multimodal Approach ◽  
Pharmaceutical Management ◽  
Veterinary Surgeons ◽  
Canine Population ◽  
Canine Osteoarthritis

Canine osteoarthritis was recently reclassified as a welfare concern by the Veterinary Companion Animal Surveillance System (VetCompass), an initiative run by the Royal College of Veterinary Surgeons, focused on improving companion animal health. This condition is a common cause for consultation in first opinion practice, with an estimated 35% of the canine population being affected. Chronic pain is complex and a multimodal approach is best for management, which includes pharmaceuticals employed in a methodical manner. This article provides an overview of the types of pain associated with canine osteoarthritis, as well as how to recognise them. Making reference to hypothetical cases, the appropriate pharmaceutical management is described. Further management strategies, as part of a multimodal approach, are summarised to ensure best practice.

scholarly journals Creation and Evaluation of the Respective Rank Problem Solution Worksheet for Improvement Pharmaceutical Management Quality

2002 ◽  
Vol 122 (8) ◽  
pp. 573-578 ◽  
Author(s):  
Masayo TANAKA ◽  
Takao ORII ◽  
Noriko KAWAI ◽  
Yoshiko KONDO
Keyword(s):  
Problem Solution ◽  
Pharmaceutical Management ◽  
Management Quality

scholarly journals Aromatherapy Versus Pharmaceutical Interventions for Dementia Related Behaviors Translating & Integrating Scholarship Practicum

2018 ◽  
Vol 3 (1) ◽  
Keyword(s):  
Side Effects ◽  
Psychotropic Drugs ◽  
Elderly Population ◽  
The Elderly ◽  
Safe Alternative ◽  
Pharmaceutical Management ◽  
Diagnosis Of Dementia ◽  
Number Of Individuals ◽  
Relaxing Effect ◽  
Pharmaceutical Interventions

The elderly population is expected to double in the next thirty years increasing the number of individuals with the diagnosis of dementia. By proxy, dementia related behaviors such as agitation, anxiety and restless will also increase. Currently, pharmaceutical management of these behaviors include Ativan, Haldol and other psychotropic drugs which have side effects that place individuals at risk for falls and at times even aggravate the behaviors. Although, not widely researched, aromatherapy is a safe alternative to treating Dementia related behaviors. Research shows aromatherapy has a calming and relaxing effect which can be measured physiologically.

scholarly journals The Trans-Tasman Therapeutic Products Authority: Potential AUSFTA Impacts on Safety and Cost-Effectiveness Regulation for Medicines and Medical Devices in New Zealand

2006 ◽  
Vol 37 (3) ◽  
pp. 365 ◽  
Author(s):  
Thomas A Faunce ◽  
Kellie Johnston ◽  
Hilary Bambrick
Keyword(s):  
United States ◽  
New Zealand ◽  
Cost Effectiveness ◽  
Medical Devices ◽  
Free Trade Agreement ◽  
Trade Agreement ◽  
Effectiveness Evaluation ◽  
Blood Products ◽  
Pharmaceutical Management ◽  
Legal Obligations

Australia and New Zealand have agreed in principle to the creation of a single agency for the regulation of pharmaceuticals and other therapeutic products in a trans-Tasman market.  The Australia New Zealand Therapeutic Products Authority (ANZTPA) is being developed to replace both the Australian Therapeutic Goods Administration (TGA) and the New Zealand Medicines and Medical Devices Safety Authority (Medsafe).  This article explores the possibility that the ANZTPA, by inheriting significant obligations imposed on the TGA under the Australia-United States Free Trade Agreement (AUSFTA), may significantly impact upon the regulation of medicines and medical devices (as well as blood products) in New Zealand.  It explores the related legal obligations and their likely consequences for New Zealand: particularly quality, safety, efficacy and cost-effectiveness evaluation processes in this area, such as those of the New Zealand Pharmaceutical Management Agency (Pharmac).

scholarly journals Importance of Introduction of Pharmaceutical Management into Clinical Path for Medicines Brought to Orthopedics Department by Patients on Hospitalization

2005 ◽  
Vol 31 (11) ◽  
pp. 951-958 ◽  
Author(s):  
Kengo Masa ◽  
Junko Fujii ◽  
Satosi Tsuruta ◽  
Kazuko Tadakuma ◽  
Tositake Yakusiji ◽  
...  
Keyword(s):  
Pharmaceutical Management

The Use of Ozone in Dentistry and Medicine

2006 ◽  
Vol os13 (1) ◽  
pp. 37-41 ◽  
Author(s):  
Aylin Baysan ◽  
Edward Lynch
Keyword(s):  
Primary Care ◽  
Management Strategy ◽  
Invasive Technique ◽  
Root Caries ◽  
Pharmaceutical Management ◽  
Primary Care Clinics ◽  
Best Management ◽  
Non Invasive ◽  
Carious Lesions ◽  
The World

A previous paper, recently published in Primary Dental Care, gave an overview of the medical uses of ozone and outlined some of its uses in dentistry. The current paper focuses on a description of use of ozone in the management of root caries and considers recent studies in this area. There has been relatively limited research into the non-invasive (pharmaceutical) management of root caries. The best management strategy still remains to be developed. Initial studies have indicated that an application of ozone for a period of either 10 or 20 seconds is capable of clinically reversing leathery root carious lesions. It is suggested that, subject to confirmation from extensive trials, this simple and non-invasive technique may benefit many patients with root caries throughout the world since this approach to treat root caries can easily be employed in primary care clinics and in the domiciliary treatment of home-bound elderly people and immobile patients in hospices and hospitals.

Budget impact analysis of two pharmaceutical management models in relation to the administration of intravenous anti-infective therapy in a Spanish nursing home

2019 ◽  
pp. ejhpharm-2019-001989
Author(s):  
Xavier Martínez-Casal ◽  
José Luis Rodriguez-Sánchez ◽  
Francisco Javier Otero-Espinar
Keyword(s):  
Nursing Home ◽  
Impact Analysis ◽  
Budget Impact ◽  
Budget Impact Analysis ◽  
Pharmaceutical Management ◽  
Management Models

scholarly journals Checking Inhaler Technique in the Community Pharmacy: Predictors of Critical Errors

Pharmacy ◽  
2020 ◽  
Vol 8 (1) ◽  
pp. 6
Author(s):  
Tatiana Makhinova ◽  
Brandie L. Walker ◽  
Marlene Gukert ◽  
LeAnna Kalvi ◽  
Lisa M. Guirguis
Keyword(s):  
Community Pharmacy ◽  
Community Pharmacists ◽  
Dose Inhaler ◽  
Community Practice ◽  
Inhaler Technique ◽  
Pharmaceutical Management ◽  
Patient Request ◽  
Metered Dose ◽  
Critical Error ◽  
Respiratory Conditions

Inhaled medications are critical in the pharmaceutical management of respiratory conditions, however, the majority of patients demonstrate at least one critical error when using an inhaler. Since community pharmacists can be instrumental in addressing this care gap, we aimed to determine the rate and type of critical inhaler errors in community pharmacy settings, elucidate the factors contributing to inhaler technique errors, and identify instances when community pharmacists check proper inhaler use. Fourth year pharmacy students on community practice placement (n = 53) identified 200 patients where at least one error was observed in 78% of participants when demonstrating inhaler technique. Prevalent errors of the users were associated with metered dose inhaler (MDI) (55.6%), Ellipta® (88.3%), and Discus® (86.7%) devices. Overall, the mean number of errors was 1.09. Possession of more than one inhaler, use of rescue inhaler, and poor control of asthma were found to be significant predictors of having at least one critical error. In all participating pharmacies, inhaler technique is mainly checked on patient request (93.0%) and for all new inhalers (79.0%).

scholarly journals SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management

2020 ◽  
Vol 178 ◽  
pp. 114114 ◽  
Author(s):  
Lin Wu ◽  
Aislinn M. O'Kane ◽  
Hu Peng ◽  
Yaguang Bi ◽  
Dagmara Motriuk-Smith ◽  
...  
Keyword(s):  
Molecular Mechanisms ◽  
Cardiovascular Complications ◽  
Pharmaceutical Management

Structural and Resource Determinants of Pharmaceutical Management Information Flow in Health Service Organizations

1996 ◽  
Vol 21 (1) ◽  
pp. 33-39 ◽  
Author(s):  
Don M. Baridam ◽  
U.N. Uwaga
Keyword(s):  
Health Service ◽  
Information Flow ◽  
Rating Scale ◽  
Service Organizations ◽  
Management Information ◽  
Pharmaceutical Management ◽  
Health Service Organizations ◽  
Composite Rating

This study by Don M Baridam and U N Uwaga examines the extent to which structural and resource factors affect pharmaceutical management information flow (PMIF) in health service organizations (HSOs) in the eastern states of Nigeria. Fifty public and 35 private HSOs were surveyed using a composite rating scale — the Pharmaceutical Management Information Battery Scale. Based on the data, the authors conclude that each component of structural and resource factors has a substantial, significant impact on PMIF.

Sign in / Sign up

Export Citation Format

Share Document